Surfactant therapy of respiratory distress syndrome

This review gives a summary of the development of a method to measure lung surfactant on gastric aspirate at birth in premature infants with the purpose to threat respiratory distress syndrome early with targeted surfactant. Machine learning was used to create the algorithm, and a point-of-care spectrometer was constructed for use in the delivery room. The sensitivity was 91% and specificity 79% in a clinical trial. The same method was used to measure surfactant in tracheal fluid in patients with COVID-19 since lung surfactant may be diminished in these patients.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:183

Enthalten in:

Ugeskrift for laeger - 183(2021), 44 vom: 01. Nov.

Sprache:

Dänisch

Beteiligte Personen:

Verder, Henrik [VerfasserIn]
Heiring, Christian [VerfasserIn]
Schousboe, Peter [VerfasserIn]

Themen:

Journal Article
Pulmonary Surfactants
Review
Surface-Active Agents

Anmerkungen:

Date Completed 15.11.2021

Date Revised 15.11.2021

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM332996565